Amalgamated Bank Axsome Therapeutics, Inc. Transaction History

Amalgamated Bank

$11.7 Billion
Q1 2025

A detailed history of Amalgamated Bank transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,269 shares of AXSM stock, worth $140,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,269

Previous 1,252 1.36%

Holding current value

$140,427

Previous $106,000 39.62%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$80.05 - $137.75 $1,360 - $2,341	17 Added 1.36%	1,269 $148,000
Q2 2024 Aug 12, 2024	BUY	$65.72 - $80.5 $2,365 - $2,898	36 Added 2.96%	1,252 $101,000
Q1 2024 Apr 23, 2024	SELL	$69.39 - $97.64 $268,816 - $378,257	-3,874 Reduced 76.11%	1,216 $97,000
Q4 2023 Feb 06, 2024	SELL	$57.42 - $83.61 $7,981 - $11,621	-139 Reduced 2.66%	5,090 $405,000
Q3 2023 Nov 08, 2023	BUY	$69.25 - $82.21 $17,797 - $21,127	257 Added 5.17%	5,229 $365,000
Q2 2023 Aug 11, 2023	BUY	$58.41 - $90.35 $25,875 - $40,025	443 Added 9.78%	4,972 $357,000
Q1 2023 May 02, 2023	SELL	$58.39 - $75.0 $43,792 - $56,250	-750 Reduced 14.21%	4,529 $279,000
Q4 2022 Feb 10, 2023	BUY	$39.94 - $79.72 $18,651 - $37,229	467 Added 9.7%	5,279 $407,000
Q3 2022 Nov 09, 2022	BUY	$36.06 - $69.85 $9,411 - $18,230	261 Added 5.74%	4,812 $215,000
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $565 - $1,215	26 Added 0.57%	4,551 $174,000
Q1 2022 Jun 30, 2022	BUY	$23.7 - $41.39 $107,242 - $187,289	4,525 New	4,525 $187,000
Q3 2021 Oct 29, 2021	SELL	$19.91 - $68.26 $104,487 - $358,228	-5,248 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $66,224 - $96,138	1,308 Added 33.2%	5,248 $354,000
Q1 2021 May 13, 2021	SELL	$55.91 - $81.44 $21,916 - $31,924	-392 Reduced 9.05%	3,940 $223,000
Q4 2020 Feb 12, 2021	BUY	$66.31 - $86.52 $1,458 - $1,903	22 Added 0.51%	4,332 $352,000
Q3 2020 Oct 30, 2020	SELL	$68.34 - $85.84 $8,405 - $10,558	-123 Reduced 2.77%	4,310 $307,000
Q2 2020 Aug 10, 2020	SELL	$49.87 - $98.69 $10,073 - $19,935	-202 Reduced 4.36%	4,433 $365,000
Q1 2020 May 13, 2020	BUY	$41.2 - $101.31 $1,936 - $4,761	47 Added 1.02%	4,635 $273,000
Q4 2019 Feb 13, 2020	BUY	$16.71 - $106.24 $76,665 - $487,429	4,588 New	4,588 $474,000

Others Institutions Holding AXSM

# of Institutions

409

Shares Held

36.6M

Call Options Held

751K

Put Options Held

568K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.74B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Axsome Therapeutics, Inc. Transaction History